Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
JLABS
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

In the media
JNJ Press releases
(-) Other news
Partner news
Press release

Period

2019

Jan
Mar
Apr
Jun
Jul
Aug

Locations & regions

EMEA

Focus area

Pharmaceuticals

Clear filters

News

Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection

Read full story

CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Device

Read full story

binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health

Read full story

X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program

Read full story

Future of healthcare discussions held at Health Horizons in Cambridge

Read full story

BioTarget Competition: Speeding up the Race to Beat Cancer

Read full story

Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38

Read full story

New Johnson & Johnson Nurses Innovate QuickFire Challenge in Perioperative Care launched at AORN Expo

Read full story

Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson

Read full story

Johnson & Johnson Innovation Awards Bloomlife the First 1000 Days QuickFire Challenge

Read full story

Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics

Read full story

Sidebar

Currently trending

Currently trending

World-leading genomics project to give insights into health and disease - In a major advance for public health, a £200m project involving the government, charity and four leading pharmaceutical companies was announced today
Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection
CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Device
binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health
X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program
Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute
Future of healthcare discussions held at Health Horizons in Cambridge
BioTarget Competition: Speeding up the Race to Beat Cancer
Johnson & Johnson Innovation Recognizes Women in STEM2D Joint Project with Griffith University
Johnson & Johnson Innovation Opens JLABS @ Shanghai in Collaboration with Shanghai Pharma Engine Company Ltd.

Trending

Trending

Johnson & Johnson Innovation, Change One Thing, Change Everything: AdoRx

Johnson & Johnson Innovation, Change One Thing, Change Everything: Chip Diagnostics

Johnson & Johnson Innovation, Change One Thing, Change Everything: Monash University